Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Papillomavirus Infections 7 Uterine Cervical Neoplasms 5 Neuroendocrine Tumors 4 Neoplasms 4 Autoimmune Diseases 3 Ovarian Neoplasms 2 Myasthenia Gravis 2 Mesothelioma, Malignant 2 Lung Neoplasms 2 Venous Thrombosis 1 Venous Thromboembolism 1 Uterine Cervical Dysplasia 1 Thyroid Diseases 1 Thrombosis 1 Squamous Intraepithelial Lesions 1 Retinal Telangiectasis 1 Renal Insufficiency 1 Recurrence 1 Prostatic Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Mesothelioma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphohistiocytosis, Hemophagocytic 1 Leukemia, Hairy Cell 1 Hemorrhage 1 Hematologic Neoplasms 1 Glioma 1 Glioblastoma 1

Interventions

Temozolomide 202 Radiotherapy 118 Bevacizumab 93 Radiation 39 Magnetic Resonance Spectroscopy 28 Irinotecan 27 Carmustine 25 Surgical Procedures, Operative 24 Lomustine 21 Erlotinib Hydrochloride 19 Chemotherapy, Adjuvant 18 Carboplatin 17 temsirolimus 13 Drug Therapy 13 O(6)-benzylguanine 12 Nivolumab 12 sargramostim 11 Sirolimus 11 Radiotherapy, Intensity-Modulated 11 Radiotherapy, Conformal 11 Sorafenib 10 Radiosurgery 10 Imatinib Mesylate 10 Everolimus 10 pembrolizumab 9 motexafin gadolinium 9 Vorinostat 9 Thalidomide 8 IL13-PE38 8 Gefitinib 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Glioblastoma × Data Collection × Clear all

NCT07499141 2026-03-30

UFGAG

Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria

Brain Neoplasms, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡